• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前庭神经鞘瘤的生长:使用生存分析的长期随访研究

Growth of vestibular schwannoma: long-term follow-up study using survival analysis.

作者信息

Kim Jong Sei, Cho Yang-Sun

机构信息

Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.

出版信息

Acta Neurochir (Wien). 2021 Aug;163(8):2237-2245. doi: 10.1007/s00701-021-04870-8. Epub 2021 May 18.

DOI:10.1007/s00701-021-04870-8
PMID:34003365
Abstract

BACKGROUND

A vestibular schwannoma (VS) is a benign nerve sheath tumor derived from the vestibular nerves. The growth rate of VS during long-term follow-up has not yet been fully evaluated. We aimed to investigate the growth rate of newly diagnosed VS and the related predictive factors for tumor growth.

METHODS

A retrospective review was performed using VS patients who underwent at least two magnetic resonance imaging (MRI) scans before tumor growth was observed. Tumor growth was defined as a size increase of more than 2 mm in the longest diameter of the tumor. To assess the growth rate of VS and related factors, we assessed tumor growth using survival analysis. Survival analysis to assess the growth rate and Cox regression analysis were performed to find related factors.

RESULTS

The study included 118 patients. The mean age of patients was 57.0 ± 12.9 years. During the observation period, the 5-year cumulative growth incidence rate was 41.3% by survival analysis. Extrameatal tumor location and hearing loss were found to be associated with an increased hazard ratio (HR) for tumor growth.

CONCLUSION

After long-term observation of VS, 41.3% of VS patients presented cumulative growth incidence rate in the first 5 years after diagnosis. Extrameatal tumor location and hearing changes were related to subsequent tumor growth.

摘要

背景

前庭神经鞘瘤(VS)是一种起源于前庭神经的良性神经鞘瘤。VS在长期随访中的生长速度尚未得到充分评估。我们旨在研究新诊断VS的生长速度以及肿瘤生长的相关预测因素。

方法

对在观察到肿瘤生长前至少接受过两次磁共振成像(MRI)扫描的VS患者进行回顾性研究。肿瘤生长定义为肿瘤最长径增加超过2毫米。为评估VS的生长速度及相关因素,我们采用生存分析评估肿瘤生长情况。进行生存分析以评估生长速度,并进行Cox回归分析以找出相关因素。

结果

该研究纳入了118例患者。患者的平均年龄为57.0±12.9岁。在观察期内,通过生存分析得出5年累积生长发生率为41.3%。发现肿瘤位于外耳道外以及听力损失与肿瘤生长的风险比(HR)增加相关。

结论

对VS进行长期观察后,41.3%的VS患者在诊断后的前5年出现累积生长发生率。肿瘤位于外耳道外以及听力变化与随后的肿瘤生长有关。

相似文献

1
Growth of vestibular schwannoma: long-term follow-up study using survival analysis.前庭神经鞘瘤的生长:使用生存分析的长期随访研究
Acta Neurochir (Wien). 2021 Aug;163(8):2237-2245. doi: 10.1007/s00701-021-04870-8. Epub 2021 May 18.
2
Gamma Knife radiosurgery for vestibular schwannoma: clinical results at long-term follow-up in a series of 379 patients.伽玛刀放射外科治疗前庭神经鞘瘤:379例患者长期随访的临床结果
J Neurosurg. 2014 Dec;121 Suppl:123-42. doi: 10.3171/2014.8.GKS141506.
3
The natural history of vestibular schwannoma.前庭神经鞘瘤的自然病史。
Otol Neurotol. 2006 Jun;27(4):547-52. doi: 10.1097/01.mao.0000217356.73463.e7.
4
Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation.立体定向放射外科治疗前庭神经鞘瘤:平均 10 年随访结果,重点关注长期听力保护。
J Neurosurg. 2016 Dec;125(Suppl 1):64-72. doi: 10.3171/2016.7.GKS161494.
5
Long-term growth rate of vestibular schwannoma in neurofibromatosis 2: A volumetric consideration.神经纤维瘤病2型中前庭神经鞘瘤的长期生长速率:体积考量
Laryngoscope. 2016 Oct;126(10):2358-62. doi: 10.1002/lary.25976. Epub 2016 Apr 14.
6
Natural History of Sporadic Vestibular Schwannoma: A Volumetric Study of Tumor Growth.散发型前庭神经鞘瘤自然史:肿瘤生长的容积学研究。
Otolaryngol Head Neck Surg. 2018 Sep;159(3):535-542. doi: 10.1177/0194599818770413. Epub 2018 Apr 24.
7
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Imaging in the Diagnosis and Management of Patients With Vestibular Schwannomas.神经外科医师学会系统评价及基于证据的指南:关于影像学在前庭神经鞘瘤患者诊断和治疗中的作用。
Neurosurgery. 2018 Feb 1;82(2):E32-E34. doi: 10.1093/neuros/nyx510.
8
Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2: a matched cohort study with sporadic vestibular schwannomas.伽玛刀放射外科治疗神经纤维瘤病 2 型伴生长性前庭神经鞘瘤患者:与散发性前庭神经鞘瘤的匹配队列研究。
J Neurosurg. 2018 Jan;128(1):49-59. doi: 10.3171/2016.9.JNS161463. Epub 2017 Jan 27.
9
Conservative management of vestibular schwannoma: Predictors of growth and hearing.前庭神经鞘瘤的保守治疗:生长和听力的预测因素
Laryngoscope. 2015 Sep;125(9):2163-8. doi: 10.1002/lary.25159. Epub 2015 Feb 3.
10
Growth rate of vestibular schwannoma.前庭神经鞘瘤的生长速率
J Clin Neurosci. 2016 Oct;32:1-8. doi: 10.1016/j.jocn.2016.05.003. Epub 2016 Jul 20.

引用本文的文献

1
A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.跨越遗传背景和解剖位置的神经鞘瘤单细胞图谱。
Genome Med. 2025 Apr 11;17(1):37. doi: 10.1186/s13073-025-01462-4.
2
Untreated Vestibular Schwannoma: Analysis of the Determinants of Growth.未治疗的前庭神经鞘瘤:生长决定因素分析
Cancers (Basel). 2024 Nov 4;16(21):3718. doi: 10.3390/cancers16213718.
3
Tumor Biology and Microenvironment of Vestibular Schwannoma-Relation to Tumor Growth and Hearing Loss.前庭神经鞘瘤的肿瘤生物学与微环境——与肿瘤生长和听力损失的关系

本文引用的文献

1
[Vestibular schwannoma. A new interpretation of tumor growth].[前庭神经鞘瘤。肿瘤生长的新解释]
Ugeskr Laeger. 2000 Oct 9;162(41):5497-500.
2
Conservative management of unilateral acoustic neuromas.单侧听神经瘤的保守治疗
Am J Otol. 2000 Sep;21(5):722-8.
Biomedicines. 2022 Dec 23;11(1):32. doi: 10.3390/biomedicines11010032.
4
Single-cell sequencing reveals the cell map and transcriptional network of sporadic vestibular schwannoma.单细胞测序揭示散发型前庭神经鞘瘤的细胞图谱和转录网络。
Front Mol Neurosci. 2022 Oct 11;15:984529. doi: 10.3389/fnmol.2022.984529. eCollection 2022.
5
Potential Molecular Biomarkers of Vestibular Schwannoma Growth: Progress and Prospects.前庭神经鞘瘤生长的潜在分子生物标志物:进展与展望
Front Oncol. 2021 Sep 27;11:731441. doi: 10.3389/fonc.2021.731441. eCollection 2021.